{"nct_id":"NCT04256707","title":"Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment","status":"COMPLETED","status_verified_date":"2025-03","start_date":"2020-01-14","start_date_type":"ACTUAL","primary_completion_date":"2024-07-31","primary_completion_date_type":"ACTUAL","completion_date":"2024-07-31","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["KPTI"]}